Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.
复制标题
DOI:
10.1038/ncomms14206
复制
发表时间:
2017-02-15
影响因子:
16.6
通讯作者:
Zanivan S
中科院分区:
文献类型:
--
作者:
Hernandez-Fernaud JR;Ruengeler E;Casazza A;Neilson LJ;Pulleine E;Santi A;Ismail S;Lilla S;Dhayade S;MacPherson IR;McNeish I;Ennis D;Ali H;Kugeratski FG;Al Khamici H;van den Biggelaar M;van den Berghe PV;Cloix C;McDonald L;Millan D;Hoyle A;Kuchnio A;Carmeliet P;Valenzuela SM;Blyth K;Yin H;Mazzone M;Norman JC;Zanivan S
The secretome of cancer and stromal cells generates a microenvironment that contributes to tumour cell invasion and angiogenesis. Here we compare the secretome of human mammary normal and cancer-associated fibroblasts (CAFs). We discover that the chloride intracellular channel protein 3 (CLIC3) is an abundant component of the CAF secretome. Secreted CLIC3 promotes invasive behaviour of endothelial cells to drive angiogenesis and increases invasiveness of cancer cells both in vivo and in 3D cell culture models, and this requires active transglutaminase-2 (TGM2). CLIC3 acts as a glutathione-dependent oxidoreductase that reduces TGM2 and regulates TGM2 binding to its cofactors. Finally, CLIC3 is also secreted by cancer cells, is abundant in the stromal and tumour compartments of aggressive ovarian cancers and its levels correlate with poor clinical outcome. This work reveals a previously undescribed invasive mechanism whereby the secretion of a glutathione-dependent oxidoreductase drives angiogenesis and cancer progression by promoting TGM2-dependent invasion. The secretome from cancer and stromal cells contributes to the creation of a microenvironment, which in turn contributes to invasion and angiogenesis. Here, the authors compare the secretomes of immortalized normal fibroblasts and cancer-derived fibroblast and identify CLIC3 as a driver of cancer progression.